These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
687 related articles for article (PubMed ID: 30016988)
41. JIP3 knockout protects mice against high fat diet-induced liver injury. Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969 [TBL] [Abstract][Full Text] [Related]
42. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications. Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518 [TBL] [Abstract][Full Text] [Related]
43. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Li M; Xu C; Shi J; Ding J; Wan X; Chen D; Gao J; Li C; Zhang J; Lin Y; Tu Z; Kong X; Li Y; Yu C Gut; 2018 Dec; 67(12):2169-2180. PubMed ID: 28877979 [TBL] [Abstract][Full Text] [Related]
44. Palmitic acid induces autophagy in hepatocytes via JNK2 activation. Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease. Shen X; Guo H; Xu J; Wang J J Cell Physiol; 2019 Aug; 234(10):18169-18179. PubMed ID: 30908654 [TBL] [Abstract][Full Text] [Related]
47. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1. Liu XL; Cao HX; Wang BC; Xin FZ; Zhang RN; Zhou D; Yang RX; Zhao ZH; Pan Q; Fan JG World J Gastroenterol; 2017 Dec; 23(46):8140-8151. PubMed ID: 29290651 [TBL] [Abstract][Full Text] [Related]
48. CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD Xie L; Wen K; Li Q; Huang CC; Zhao JL; Zhao QH; Xiao YF; Guan XH; Qian YS; Gan L; Wang LF; Deng KY; Xin HB Int J Biol Sci; 2021; 17(15):4305-4315. PubMed ID: 34803499 [TBL] [Abstract][Full Text] [Related]
49. Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice. Choi YJ; Lee KY; Jung SH; Kim HS; Shim G; Kim MG; Oh YK; Oh SH; Jun DW; Lee BH Toxicol Appl Pharmacol; 2017 Feb; 316():74-82. PubMed ID: 28038998 [TBL] [Abstract][Full Text] [Related]
50. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice. Yao L; Wang C; Zhang X; Peng L; Liu W; Zhang X; Liu Y; He J; Jiang C; Ai D; Zhu Y Hepatology; 2016 Jul; 64(1):92-105. PubMed ID: 26928949 [TBL] [Abstract][Full Text] [Related]
51. Loss of NAT10 alleviates maternal high-fat diet-induced hepatic steatosis in male offspring of mice. Zhang QR; Zhang JB; Shen F; Xue R; Yang RX; Ren TY; Fan JG Obesity (Silver Spring); 2024 Jul; 32(7):1349-1361. PubMed ID: 38816990 [TBL] [Abstract][Full Text] [Related]
52. Lepr(db/db) Mice with senescence marker protein-30 knockout (Lepr(db/db)Smp30(Y/-)) exhibit increases in small dense-LDL and severe fatty liver despite being fed a standard diet. Kondo Y; Hasegawa G; Okada H; Senmaru T; Fukui M; Nakamura N; Sawada M; Kitawaki J; Okanoue T; Kishimoto Y; Amano A; Maruyama N; Obayashi H; Ishigami A PLoS One; 2013; 8(6):e65698. PubMed ID: 23755269 [TBL] [Abstract][Full Text] [Related]
53. Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression. Su Y; Chen Q; Ma K; Ju Y; Ji T; Wang Z; Li W; Li W Pharmacol Rep; 2019 Apr; 71(2):319-329. PubMed ID: 30826573 [TBL] [Abstract][Full Text] [Related]
54. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy. Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095 [TBL] [Abstract][Full Text] [Related]
55. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023 [TBL] [Abstract][Full Text] [Related]
56. Sesamin ameliorates nonalcoholic hepatic steatosis by inhibiting CD36-mediated hepatocyte lipid accumulation in vitro and in vivo. Bai YP; Zhang T; Hu ZY; Zhang Y; Wang DG; Zhou MY; Zhang Y; Zhang F; Kong X Biochem Pharmacol; 2024 Jun; 224():116240. PubMed ID: 38679210 [TBL] [Abstract][Full Text] [Related]
57. Prolactin improves hepatic steatosis via CD36 pathway. Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209 [TBL] [Abstract][Full Text] [Related]
58. COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR. Zhang CY; Tan XH; Yang HH; Jin L; Hong JR; Zhou Y; Huang XT Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897843 [TBL] [Abstract][Full Text] [Related]